PRL-8-53

Khoom npe: PRL-8-53

CAS: 51352-87-5

MF: C18H22ClNO2

MW: 319.82578

EINECS: 206-141-6

Daim ntawv: Crystalline solid Powder

PRL-8-53 Cov ntaub ntawv tshuaj

 

Daim ntawv thov: PRL-8-53 yog cov tshuaj tshawb fawb nootropic muab tau los ntawm benzoic acid thiab phenylmethylamine nrog rau kev nco-txhim kho cov teebmeem, siv hauv kev tshawb fawb txog neuroscience ntsig txog kev nco txhim kho thiab tiv thaiv kev puas hlwb.

Cov tsos mob: Dawb los yog tawm-dawb hmoov

Lub cev lub cev: Khoom

Solubility: Soluble rau 25 mM hauv Ethanol, Soluble rau 50 mM hauv dej.

Cia: Khaws rau ntawm chav tsev kub lossis txias dua, hauv lub thawv ntim airtight, tiv thaiv tshav kub, lub teeb thiab av noo.

Stability: ruaj khov rau tsawg kawg yog ob xyoos thaum khaws cia raws li saum toj no.

PRL-8-53 yog ib qho khoom siv nootropic ntxiv, txhais tau tias nws tau tsim hauv chav kuaj. Nws lub npe puv yog methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate.

Cov kws tshawb nrhiav pom tias qhov ncauj ntxiv ntawm PRL-8-53 tuaj yeem txhim kho kev zam kev kawm hauv nas. Ib qho kev tshawb fawb tib neeg kuj tau ua tiav ntawm PRL-8-53. Txhua tus neeg koom nrog tau noj cov placebo thiab PRL -8-53, nyob rau lub sijhawm sib cais, hauv kev tshawb nrhiav ob qhov muag tsis pom kev. Cov neeg koom nrog tom qab ntawd tau xeem qhov kev sim nco, suav nrog kaum ob lo lus monosyllabic hauv ib qho kev txiav txim. Qhov kev ntsuam xyuas tau ua peb zaug, tam sim ntawd tom qab supplementation, ib hnub tom qab supplementation, thiab plaub hnub tom qab supplementation.

Cov neeg uas nco qab ntau tshaj yim lo lus tom qab noj cov placebo tau ntsib cov txiaj ntsig me me, tab sis cov neeg muaj hnub nyoog 30 xyoo lossis tsis nco qab tau txais txiaj ntsig zoo los ntawm kev ntxiv. Qee zaum, lawv cov qhab nia ntawm lo lus xeem tau nce ob npaug.

Tsis muaj kev phiv tshwm sim hauv tib neeg txoj kev tshawb fawb, thiab cov pov thawj ua ntej nas qhia tias PRL-8-53 muaj kev nyab xeeb. Siv PRL-8-53 raws li kev noj zaub mov ntxiv, txawm li cas los xij, tsis tuaj yeem pom zoo rau lub sijhawm no vim tias nws yog cov khoom siv hluavtaws thiab tag nrho cov pov thawj rau nws cov teebmeem yog los ntawm cov kev tshawb fawb tau nyiaj los ntawm tus tuav ntaub ntawv patent. Txawm hais tias qhov txuas no yuav tsum tsis lees paub cov pov thawj muaj, kev luam tawm ywj pheej yuav mus ntev mus rau kev lees paub PRL-8-53 qhov ua tau zoo.

Ib qho ntawm PRL-8-53 cov txiaj ntsig tseem ceeb yog nws lub peev xwm los txhawb cov dopamine thiab, ua rau muaj txiaj ntsig zoo rau kev tsim lub cim xeeb.

Qhov no yog vim qhov nce qib dopamine txuas rau kev txhim kho tseem ceeb hauv kev hloov pauv thiab ua haujlwm nco.

PRL-8-53 cov khoom siv tshuaj lom neeg yog cov tseem ceeb rau qhov txiaj ntsig zoo li no vim nws yog tsim los ntawm kev sib txuas ntawm phenylethylamine thiab benzoic acid.

Phenylethylamine (PEA) paub txog kev txhim kho lub cev muaj zog hauv cov tsiaj.

Cov kev tshawb fawb tsiaj pom tau hais tias phenylethylamine (los ntawm PRL-8-53) txhim kho nas 'kev zam kev kawm thiab tus cwj pwm locomotor.

Ib txoj kev tshawb fawb tib neeg ntawm PRL-8-53 kuj lees paub nws lub zog ua lub cim xeeb txhim kho raws li nws pom muaj peev xwm txhim kho kev kawm thiab pab khaws cov lus qhia.

Thaum PRL-8-53 txhim kho kev nco mus ntev thiab txo qis kev txawj ntse. Nws qhov cuam tshuam rau lub sijhawm luv luv tsis meej heev.

Yuav tsum muaj pov thawj ntxiv los txiav txim siab npaum li cas rau PRL{{0}}. Cov koob tshuaj zoo yuav txawv, txij li tib neeg txoj kev tshawb fawb ntawm PRL -8-53 siv ib koob tshuaj ntawm 5mg, thaum cov ntaub ntawv patent ntawm PRL-8-53 qhia txog ntau npaum li cas ntawm 0.{{5} }mg/kg, nrog rau qhov 'zoo tagnrho' ntau ntawm 0.05-1.2mg/kg.

Cim npe nrov: prl-8-53, Tuam Tshoj prl-8-53 lwm tus neeg